Phentermine

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Adipex-P (Teva); Behapront; Diminex; Ionamin (Celltech); Lomaira (Avanthi); Minobese-Forte; Panbesy; Panbesyl; Qsymia (Vivus); Redusa; Suprenza; Umine; Zantryl
  • INDICATIONS: Obesity
  • CLASS: Amphetamine
  • HALF-LIFE: 19–24 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Fluoxetine, Fluvoxamine, MAO inhibitors, Paroxetine Hydrochloride, Phenelzine, Sertraline, Tranylcypromine

PREGNANCY CATEGORY: X

NOTE

Qsymia is phentermine and topiramate.

Our database has 49 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 12/30/2022

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top